DENGVAXIA, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION
Product details
Registration number: SIN15096P
Classification: Prescription Only
Active ingredients:
- CYD Dengue Virus Serotype 1
- CYD Dengue Virus Serotype 2
- CYD Dengue Virus Serotype 3
- CYD Dengue Virus Serotype 4
Strength:
- 4.5 - 6.0 log10 CCID50/dose
- 4.5 - 6.0 log10 CCID50/dose
- 4.5 - 6.0 log10 CCID50/dose
- 4.5 - 6.0 log10 CCID50/dose
Dosage form: INJECTION, POWDER, FOR SUSPENSION
Route: SUBCUTANEOUS
Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.
ATC code: J07BX
HSA approval date: 11 October 2016
Manufacturer(s): Sanofi Pasteur (VDR) (Drug Product and Diluent)
Manufacturing country/countries: FRANCE
What are the HSA registration number and classification for DENGVAXIA, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15096P
Classification: Prescription Only
What active ingredients and strength are recorded for DENGVAXIA, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- CYD Dengue Virus Serotype 1
- CYD Dengue Virus Serotype 2
- CYD Dengue Virus Serotype 3
- CYD Dengue Virus Serotype 4
Strength:
- 4.5 - 6.0 log10 CCID50/dose
- 4.5 - 6.0 log10 CCID50/dose
- 4.5 - 6.0 log10 CCID50/dose
- 4.5 - 6.0 log10 CCID50/dose
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for DENGVAXIA, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SUSPENSION
Route: SUBCUTANEOUS
Who is the recorded registrant for DENGVAXIA, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for DENGVAXIA, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Sanofi Pasteur (VDR) (Drug Product and Diluent)
Manufacturing country/countries: FRANCE
Where can I look up DENGVAXIA, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15096P or the exact product name DENGVAXIA, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION. The general register link does not preselect this product.
What are the source dates for this DENGVAXIA, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this DENGVAXIA, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15096P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)